Log in
Enquire now
Nurix Therapeutics

Nurix Therapeutics

Nurix Therapeutics is a small Molecules.

OverviewStructured DataIssuesContributors

Contents

nurixtx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Location
San Francisco
San Francisco
0
B2X
B2B
B2B
0
CEO
‌
Arthur T. Sands
0
Legal Name
Nurix Therapeutics, Inc.0
Number of Employees (Ranges)
51 – 200
Email Address
info@nurix-inc.com0
Phone Number
+141566053200
Number of Employees
2420
Full Address
1700 Owens Street Suite 205 San Francisco, CA 94158 United States0
CIK Number
1,549,5950
Place of Incorporation
Delaware
Delaware
0
DUNS Number
0784465430
IRS Number
270,838,0480
Total Funding Amount (USD)
120,000,000
Latest Funding Round Date
March 12, 2020
Stock Symbol
NRIX0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
‌
Lori A. Kunkel
0
‌
David L. Lacey
0
‌
Judith A. Reinsdorf
0
‌
Julia Gregory
0
‌
Arthur T. Sands
0
CFO
‌
Johannes Van Houte (entrepreneur)
0
CAGE Code
8DFY70
Patents Assigned (Count)
1
COO
‌
Stefani A. Wolff
0
Country
United States
United States

Other attributes

Company Operating Status
Active0
Contact Page URL
nurixtx.com/contact/
Previous Name
Nurix, Inc.0
SIC Code
2,8340
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Nurix Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.